Advertisement

You are subscribed to the Medical Economics eNews.

March 26, 2015

ACC 2015
Twitter Facebook

View Online  |  Download Magazine  |  Share With A Colleague  |  Print & Digital Subscribe  |  eNewsletter Subscribe

ACC 2015 POST-CONFERENCE BRIEF
More Takeaways and Commentaries ...

The American of Cardiology 64th Annual Scientific Session and Expo provided an interesting mix of clinical and practice management topics. Here are summaries of a few session takeaways along with commentaries by subject area experts.

Highlights

ACOs show payment reform is possible

"The health care system must transform and payment reform represents one pathway that is rapidly diffusing," according to Michael Chernew, PhD. » More on reform strategies

The complexity of atrial fibrillation

"Atrial fibrillation, once thought of as a disease with a simple diagnosis, is emerging as a disease of great complexity and one needing a great deal of clinical judgment to manage effectively," said Valentin Fuster, MD. » Understand the management challenges

Old guidelines still appropriate for blood-pressure targets

Despite recently published hypertension guidelines that recommend a new target for blood pressure lowering in individuals starting at age 60, it is still appropriate to continue to focus on targets set by an older guideline, according to Jackson T. Wright, Jr., MD, PhD. » Read more on this issue

Cardiologists need to engage in tort reform

Given the cycles of medical liability issues, it is important that physicians get involved at the state level to help maintain the gains made over the past decade that have shifted toward more physician-friendly tort reforms, according to Joseph S. Wilson, MD. » Learn more about reform

Advertisement
DISCLAIMER:
This information has been independently developed and provided by the editors of Medical Economics.
The Medical Economics brand and this e-newsletter are in no way affiliated with the conference event or parent organization. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logoUBM Advanstar logo